Teva Sticks With 10% Discount For Trastuzumab
Launch Discount For Herzuma Biosimilar Matches That Offered For Rituximab
Teva and Celltrion have launched their Herzuma trastuzumab biosimilar in the US at a 10% discount to the Herceptin brand. The discount matches that offered for their Truxima rituximab biosimilar and compares to steeper discounts offered by competing biosimilars.
